S5 - E24.4 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Implications for GLI
Send us a text In the second half of Roger Green's interview with Global Liver Institute Vice President, Liver Programs Jeff McIntyre, Jeff discusses the implications of his key EASL Congress takeaways for GLI and other patient advocacy groups. To Jeff, this trend makes patient advocates a more valuable player in the clinical trial design process, particularly when coupled with the FDA's increasing focus on diversity in trial populations. This will become particularly important becaus...
8 Aug 202418min
S5 - E24.3 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Takeaways
Send us a text This conversation contains the first half of Roger Green's interview with Global Liver Institute Vice President, Liver Programs Jeff McIntyre, during which the two discuss what Jeff considered the key strategic takeaways for GLI from the various EASL Congress presentations, abstracts and discussions. Jeff focuses on the "overriding sense of optimism" coming from the multiple pieces of positive drug data. He cites the data on Boehringer Ingelheim's survodutide, the follow...
7 Aug 202412min
S5 - E24.2 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Implications
Send us a text In the second half of Roger Green's interview with PharmaNest Founder and CEO Mathieu Petitjean, Matt discusses the implications of his key EASL Congress takeaways for PharmaNest. Matt starts this discussion with a simple question: Will biopsy-based analyses become part of a surrogate endpoint? As he points out, they are not today, and creating the necessary data might require a significant effort. If not, they are unlikely to remain relevant to the large, Phase 3 trial...
7 Aug 202410min
S5 - E24.1 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Takeaways
Send us a text This conversation contains the first half of Roger Green's interview with PharmaNest Founder and CEO Mathieu Petitjean. After Matt tells the audience a little about his background and PhramaNest, the two discuss what Matt considered the key strategic takeaways for PharmaNest from the various EASL Congress presentations, abstracts and discussions. Before answering the question, Matt describes the core services his company offers: "PharmaNest specializes in digital patholo...
7 Aug 202417min
S5 - E24 - A view of MASLD: Looking back at EASL Congress from six weeks later
Send us a text 00:00:00 - Surf's Up: Season 5 Episode 24 This week's episode on MASLD lessons from the EASL Congress 2024 includes three separate elements: individual interviews with PharmaNext Founder and CEO Mathieu Petitjean and Global Liver Institute Vice President of Liver Programs Jeff McIntyre, followed by a discussion with patient advocates Mike Betel of the Fatty Liver Alliance and José Willemse from the Netherlands, now supporting EASL. 00:02:45 - Introduction Rog...
3 Aug 20241h 16min
S5 SPECIAL 5 - Reviewing EASL Congress: Louise Campbell 3 (first-time material)
Send us a text This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder and Clinical Director Louise Campbell took place on the last day of the Congress This portion of the conversation was not included in the original S5 E19 but instead was reserved for a special conversation at a later time (now). The specific focus of this conversation is on how practice pattern...
21 Juli 20249min
S5 SPECIAL 4 - Reviewing EASL Congress: Sven Francque
Send us a text This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with Hepatology Key Opinion Leader and EASL Educational Councillor Sven Francque took place 90 minutes after the EASL Congress closed. The discussion focuses on plans and hopes for the future, both the future of MASLD diagnosis and treatment and of the EASL Congress itself. The conversation starts with Sven discussing all the positive energy co...
20 Juli 202417min
S5 SPECIAL 3 - Reviewing EASL Congress: Louise Campbell 2
Send us a text This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder and Clinical Director Louise Campbell took place on the last day of the Congress. This conversation centered on three major topics addressed at the EASL Congress, each of which made Louise "quite enthusiastic." The first of these was the presentation of the new EASL/EASD/EASO Clinical Practice ...
20 Juli 202420min
